ÀÓ¼±¿µ

ÀÓ¼±¿µ

ÀÓ¼±¿µ ±³¼öÀÇ Áø·á½Ã°£Ç¥ Áø·á¿¹¾à

Áø·á°ú/¼¾ÅÍ ¿ù È­ ¼ö ¸ñ ±Ý Åä Àü¹®Áø·á°ú¸ñ
¼ÒÈ­±â³»°ú -
Á¾ÀÏ
¿ÀÀü
¿ÀÈÄ
- - °£¾Ï, °£°æº¯Áõ (°£°æÈ­), °£¿°, °£Á¾¾ç
¾Ïº´¿ø - - - -
¿ÀÀü
- °£¾Ï, °£°æº¯Áõ (°£°æÈ­), °£¿°, °£Á¾¾ç

ÀÓ¼±¿µ ±³¼öÀÇ »ó¼¼Á¤º¸

ÇзÂ

more
  • 2001 .03  ~  2007 .02  :  °í·Á´ëÇб³ Àǰú´ëÇÐ Çлç
  • 2009 .01  ~  2011 .08  :  °í·Á´ëÇб³ Àǰú´ëÇÐ ¼®»ç
  • 2012 .03  ~  2016 .02  :  °í·Á´ëÇб³ Àǰú´ëÇÐ ¹Ú»ç

°æ·Â

more
  • 2007 .03  ~  2008 .02  :  °í·Á´ëÇб³ ÀÇ·á¿ø ÀÎÅÏ ¼ö·á
  • 2008 .03  ~  2012 .02  :  °í·Á´ëÇб³ ÀÇ·á¿ø ³»°ú Àü°øÀÇ ¼ö·á
  • 2012 .03  ~  2017 .02  :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø ¼ÒÈ­±â³»°ú ÀÓ»ó°­»ç
  • 2016 .03  ~  2018 .02  :  MD Anderson Cancer Center¿¡¼­ Research Fellowship
  • 2017 .03  ~  2020 .08 .31 :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø ¼ÒÈ­±â³»°ú ÀÓ»óÁ¶±³¼ö
  • 2020 .09  ~  2021 .08 .31 :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø ¼ÒÈ­±â³»°ú Á¶±³¼ö
  • 2021 .09 .01 ~   :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø ¼ÒÈ­±â³»°ú ºÎ±³¼ö

¼ö»ó³»¿ª

more
  • 2015  :  Best Presentation Winner, The liver week 2015 (´ëÇѰ£ÇÐȸ)
  • 2018  :  Best Presentation Winner, The liver week 2018 (´ëÇѰ£ÇÐȸ)

ÇÐȸȰµ¿

more
  • 2013 .06  ~   :  ¼ÒÈ­±â ³»½Ã°æÇÐȸ Á¤È¸¿ø
  • 2013 .03  ~   :  ´ëÇѰ£ÇÐȸ Á¤È¸¿ø
  • 2012 .06  ~   :  ´ëÇѰ£¾ÏÇÐȸ Á¤È¸¿ø
  • 2012 .03  ~   :  ³»°úÇÐȸ Á¤È¸¿ø
  • 2015  ~  2016  :  ´ëÇѰ£¾ÏÇÐȸ °£ÇàÀ§¿ø
  • 2018  ~  2016  :  ´ëÇѰ£¾ÏÇÐȸ ÇмúÀ§¿ø
  • 2019  ~  2021  :  ´ëÇѰ£¾ÏÇÐȸ ÇмúºÎ°£»ç
  • 2019  ~  2021  :  ´ëÇѰ£¾ÏÇÐȸ ¿¬±¸À§¿ø
  • 2019  ~  2021  :  ´ëÇѰ£ÇÐȸ Á¤Ã¥À§¿ø
  • 2019  ~  2021  :  ´ëÇѰ£ÇÐȸ ¿¬±¸À§¿ø
  • 2021  ~   :  ´ëÇѰ£ÇÐȸ ÇмúÀ§¿ø
  • 2021  ~   :  ´ëÇѰ£ÇÐȸ ±³À°À§¿ø
  • 2021  ~   :  ´ëÇѰ£¾ÏÇÐȸ °£Çà

³í¹®

more
  • [SCI] (Evaluation of the severity of nonalcoholic fatty liver disease through analysis of serum exosomal miRNA expression)
  • [SCI] (Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease)
  • [SCI] (Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B)
  • [SCI] (An Overview of the Genomic Characterization of Hepatocellular Carcinoma)
  • [SCOPUS] (Early Normalization of Alanine Aminotransferase during Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in HBV Patients)
  • [SCI] (Pathological predictive factors for late recurrence of hepatocellular carcinoma in chronic liver disease)
  • [SCI] (Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure)
  • [±¹³»³í¹®] (Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis)
  • [SCI] (Survival according to recurrence patterns after resection for transplantable hepatocellular carcinoma in HBV endemic area: Appraisal of liver transplantation strategy)
  • [SCI] (Low ARID1A Expression is Associated with Poor Prognosis in Hepatocellular Carcinoma)
  • [SCI] (Low ARID1A Expression is Associated with Poor Prognosis in Hepatocellular Carcinoma)
  • [SCI] (Identification of prognostic biomarker in predicting hepatocarcinogenesis from cirrhotic liver using protein and gene signatures)
  • [SCI] (Survival according to recurrence patterns after resection for transplantable hepatocellular carcinoma in HBV endemic area: Appraisal of liver transplantation strategy)
  • [SCOPUS] (Genomic Perspective on Mouse Liver Cancer Models)
  • [SCI] (Genomic Perspective on Mouse Liver Cancer Models)
  • [SCI] (The epidemiology of hepatitis B virus infection in Korea)
  • [SCI] (Molecular Subtypes and Genomic Signatures of Hepatocellular Carcinoma for Prognostication and Therapeutic Decision-Making)
  • [SCI] (Identification of prognostic biomarker in predicting hepatocarcinogenesis from cirrhotic liver using protein and gene signatures)
  • [SCI] (Comparison of 2 curative treatment options for very early hepatocellular carcinoma: Efficacy, recurrence pattern, and retreatment)
  • [SCI] (Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide)
  • [SCI] (NELFE-Dependent MYC Signature Identifies a Unique Cancer Subtype in Hepatocellular Carcinoma)
  • [SCI] (Clinical significance of APOB inactivation in hepatocellular carcinoma)
  • [SCI] (Integrated Genomic Comparison of Mouse Models Reveals Their Clinical Resemblance to Human Liver Cancer)
  • [SCI] (Daily Norfloxacin vs. Weekly Ciprofloxacin to Prevent Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial)
  • [SCI] (Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B)
  • [SCI] (Glutamine synthetase mediates sorafenib sensitivity in ¥â-catenin-active hepatocellular carcinoma cells)
  • [SCI] (Platelets reduce anoikis and promote metastasis by activating YAP1 signaling)
  • [SCI] (Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma)
  • [SCI] (Diagnostic performance of gadoxetic acid (Primovist)-enhanced MR imaging versus CT during hepatic arteriography and portography for small hypervascular hepatocellular carcinoma)
  • [SCI] (Treatment Response and Long-Term Outcome of Peginterferon ¥á and Ribavirin Therapy in Korean Patients with Chronic Hepatitis C)
  • [SCI] (The management and prognosis of patients with hepatocellular carcinoma: what has changed in 20 years?)
  • [SCI] (BCLC stage B is a better designation for single large hepatocellular carcinoma than BCLC stage A)
  • [SCI] (Risk factors for developing hyponatremia during terlipressin treatment: A retrospective analyses in variceal bleeding)
  • [SCI] (The risk of perioperative adverse events in patients with chronic liver disease)
  • [SCI] (Role of hepatitis B surface antigen (HBsAg) in identifying true inactive HBsAg carriers infected with genotype C hepatitis B virus)
  • [SCI] (Clinical Significance of HBV Precore and Core Promoter Variants in Korean Patients With Chronic Hepatitis B)
  • [SCI] (Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis.)
  • [±¹³»³í¹®] (Gastrectomy for the Treatment of Refractory Gastric Ulceration after Radioembolization with 90Y Microspheres)
  • [±¹³»³í¹®] (Spinal cord injury after conducting transcatheter arterial chemoembolization for costal metastasis of hepatocellular carcinoma)
  • [±¹³»³í¹®] (Optimal time for repeating the IgM anti-hepatitis A virus antibody test in acute hepatitis A patients with a negative initial test.)
  • [±¹³»³í¹®] (Rifampin-induced Pseudomembranous Colitis with Rectosigmoid Sparing)

Àú¼­

more
  • Hepatocellular Carcinoma: Translational Precision Medicine Approaches
  • Experimental Models of Liver Cancer

ÃÖÁ¾¼öÁ¤ÀÏ : 2021.12.10